Verve Ventures's Biotechnology Portfolio

Medyria is a Swiss medtech startup that engineers technologies for cardiovascular catheter navigation and sensing.

Kyron.bio uses the power of glycan alterations to enable improved protein therapies.

True precision medicine through single-cell science

Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested.

MultiOmic Health is building a precision therapeutics discovery platform for metabolic syndrome diseases

Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.

FineHeart is a medical device company

Orakl Oncology is a precision oncology company that combines data and biology to bring new drugs to cancer patients.

Comphya developing an active implantable medical device to restore the erectile function of patient non-responsive to oral drugs.

Biograil is a biotech company manufacturing an oral device for delivery of biologics

Wildbiene + Partner contributes to a balanced ecosystem by providing sustainable pollination and high-quality bee experiences.

Limula offers a modular and automated solution for on-demand and at-scale manufacturing of cell therapies.

IRUBIS offers bioprocessing and infrared spectroscopy services.

A Paris-based biotechnology company .

Qnami develops quantum sensing technologies designed for nanoscale imaging.